NCT03748706View on ClinicalTrials.gov

PTI-125 for Mild-to-moderate Alzheimer's Disease Patients

PHASE2CompletedINTERVENTIONAL

Enrollment

13

Participants

Timeline

Start Date

March 7, 2019

Primary Completion Date

May 8, 2019

Study Completion Date

May 8, 2019

Conditions

Alzheimer Disease

Interventions

DRUG

PTI-125, 100 mg tablets

PTI-125, 100 mg tablets taken twice a day for 28 days

Trial Locations (2)

75115

Insite Clinical Research, DeSoto

78229

Clinical Trials of Texas, San Antonio

Sponsors

Lead Sponsor

Pain Therapeutics

All Listed Sponsors

collaborator

National Institute on Aging (NIA)

NIH

lead

Pain Therapeutics

INDUSTRY

NCT03748706 - PTI-125 for Mild-to-moderate Alzheimer's Disease Patients | Biotech Hunter | Biotech Hunter